Search - tctmd.com

Displaying 681 - 700 of 909

Sort: Relevancy | Date

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

Functional Risk Scoring: Fame 3 and Beyond

Presenter: Kevin J. Beatt, Craig R. Smith, William F. Fearon

October 11, 2015

Presentation TCT 2015

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Presenter: Taehoon Ahn, Robert C. Welsh, Christian Juhl Terkelsen

October 11, 2015

Presentation TCT 2015

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

Presenter: Kevin J. Beatt, Craig R. Smith, Davide Capodanno

October 11, 2015

Presentation TCT 2015

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

Presenter: Taehoon Ahn, Robert C. Welsh, Leif Thuesen

October 11, 2015

Presentation TCT 2015

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Presenter: Kevin J. Beatt, Craig R. Smith, Philippe Généreux

October 11, 2015

Presentation TCT 2015

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

Presenter: Kevin J. Beatt, Craig R. Smith, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Antoniucci

October 11, 2015

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation

Medical Therapy vs Revascularization for StableCAD Pts With Unclassified Appropriateness Score

Presenter: M. Shuvy

October 07, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

Presentation

Complete Revascularization with Hemodynamic Support

Presenter: Ehtisham Mahmud

July 11, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Complete Revascularization in STEMI and Multivessel Disease

Presenter: M. Kowalewski

June 10, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

Presentation Fellows 2015

Case 2

Presenter: Jeffrey W. Moses, Manish A. Parikh, Michael J. Lim

May 16, 2015

Presentation Fellows 2015

Case 1

Presenter: Jeffrey W. Moses, Manish A. Parikh, Ziad A. Ali

May 16, 2015

Presentation Fellows 2015

Rationale for Revascularization in Stable Ischemic Heart Disease

Presenter: Jeffrey W. Moses, Manish A. Parikh, Ajay J. Kirtane

May 16, 2015

Presentation

Long-term Prognosis of Complete Percutaneous Coronary Revascularization in Patients With Diabetes and Multivessel Disease

Presenter: MF. Jim?nez-Navarro

May 07, 2015

Advertisement

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Functional Risk Scoring: Fame 3 and Beyond

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Medical Therapy vs Revascularization for StableCAD Pts With Unclassified Appropriateness Score

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Complete Revascularization with Hemodynamic Support

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Complete Revascularization in STEMI and Multivessel Disease

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Case 2

Case 1

Rationale for Revascularization in Stable Ischemic Heart Disease

Long-term Prognosis of Complete Percutaneous Coronary Revascularization in Patients With Diabetes and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content